NCT07349641 2026-03-17
A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer
National Cancer Institute (NCI)
Phase 2 Not yet recruiting
Clinical Trials
8 trialsNCT07107334 2026-02-18
A Study to Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia
University of Florida
Phase 2 Recruiting
NCT02397083 2026-02-13
LEVER
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT06464107 2026-02-09
Endometrial Cell Collection With the PadKit
Hackensack Meridian Health
Phase NA Recruiting
NCT07377734 2026-01-30
A Multicenter, Randomized, Open-Label, Controlled Clinical Trial of Intrauterine Injection of Recombinant Humanized Type III Collage in the Fertility-Sparing Treatment of Endometrial Cancer or Atypical Hyperplasia
Peking University People's Hospital
Phase 2 Not yet recruiting
NCT05903131 2026-01-20
Uterine Preservation Via Lifestyle Transformation
Washington University School of Medicine
Phase 2 Recruiting
NCT07078838 2026-01-16
Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer
UNC Lineberger Comprehensive Cancer Center
Phase 2 Not yet recruiting
NCT03671811 2026-01-06
Megestrol Acetate With or Without Pterostilbene in Treating Patients With Endometrial Cancer Undergoing Hysterectomy
City of Hope Medical Center
Phase 2 Active not recruiting